Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the pharmacokinetics of CP-690,550 in subjects with mild, moderate or
severe renal impairment, who do not require hemodialysis, compared to healthy controls.